Who are the key players in North America ASEAN Point of Care Diagnostics Market industry?

The top 5 players in the North America ASEAN Point of Care Diagnostics market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Becton Dickinson and Company, and Danaher Corporation. These companies lead the market through innovation, comprehensive product portfolios, global reach, and ongoing strategic collaborations to enhance rapid diagnostic solutions.

Which segment accounted for the largest North America ASEAN Point of Care Diagnostics Market share?

In 2023, infectious disease testing held the largest market share in the North America ASEAN Point of Care Diagnostics market. This dominance is attributed to the growing prevalence of diseases such as influenza, HIV, and COVID-19, as well as the widespread implementation of rapid point-of-care testing in both clinical and remote settings.

What are the factors driving the North America ASEAN Point of Care Diagnostics Market?

Key drivers include the increasing prevalence of chronic diseases, the need for rapid results, and technological advancements. For example, Siemens Healthineers’ latest point-of-care molecular diagnostics platforms have facilitated quicker diagnosis and patient management, supporting greater adoption in both developed and rural regions across North America and ASEAN.

Which type accounted for the largest North America ASEAN Point of Care Diagnostics Market share?

Lateral flow assays accounted for the largest share in the North America ASEAN Point of Care Diagnostics market. Their ease of use, affordability, and suitability for a wide range of target analytes, including infectious disease markers and pregnancy, have driven their widespread acceptance and dominance across healthcare settings.

Home Healthcare

North America ASEAN Point of Care Diagnostics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America ASEAN Point of Care Diagnostics Market
Brand: Bussiness Insights

North America ASEAN Point of Care Diagnostics Market: by Type (Glucose Monitoring, Infectious Disease Testing, Cardiometabolic Monitoring, Pregnancy & Fertility Testing, Hematology Testing, Others), Application (Hospitals, Clinics, Homecare, Ambulatory Care, Diagnostic Centers, Others), Distribution Channels (Direct Tenders, Retail, Online, Distributors, Pharmacies, Others), Technology (Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Microfluidics, Dipsticks, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20235

North America ASEAN Point of Care Diagnostics Market Outlook 2025-2035

The North America ASEAN Point of Care Diagnostics Market encompasses rapid diagnostic tools and solutions enabling real-time detection of various diseases at or near the site of patient care. Point of care diagnostics offer significant advantages in terms of faster diagnosis, improved patient outcomes, and reduced dependence on centralized laboratories. Key technological innovations, rising prevalence of chronic and infectious diseases, and increasing demand for home healthcare are reshaping the market landscape. With progressive technological advances in molecular diagnostics, microfluidics, and immunoassays, the market is experiencing robust growth and transformation. Supportive government regulations for decentralized diagnostics and expansion of digital health infrastructure are anticipated to further propel adoption across North America.

Latest Market Dynamics

Key Drivers

Rising prevalence of chronic and infectious diseases: With increasing cases of diabetes, cardiovascular diseases, and infectious outbreaks, the need for rapid and reliable diagnostics has surged. In 2025, companies like Abbott Laboratories

Shift toward decentralized and home-based care: Patients and providers increasingly prefer diagnostic solutions for use outside of traditional hospital settings. QuidelOrtho Corporation launched new at-home test kits in 2025, broadening market reach.
Adoption of digital connectivity and cloud integration: The market is seeing rising traction for POC devices with digital data sharing capabilities. Roche pushed connectivity features in its POC systems, meeting higher demand for integrated healthcare solutions.

Expansion in personalized medicine and rapid infectious disease detection: The ability of POC diagnostics to deliver tailored results is fueling demand for advanced platforms, especially as COVID-19 variants persist in 2025. bioMérieux SA expanded its molecular diagnostic offerings for emerging pathogens.
Growth in ambulatory and remote care markets: Remote patient monitoring solutions are unlocking opportunities for market penetration in underserved populations. BD (Becton, Dickinson and Company) announced new partnerships in 2025 to enhance diagnostic access in rural North America.

Quality control and regulatory compliance: The variability in product performance and differing regulatory frameworks can hinder adoption. EKF Diagnostics faces ongoing challenges to harmonize product standards for North American approval.
Integration with existing clinical workflows: Ensuring seamless interoperability with hospital information systems is a persistent challenge. Companies like Sysmex Corporation are investing in middleware solutions to address these integration issues.

High cost of advanced point of care technologies: Significant investment in R&D escalates end-user prices. Danaher Corporation has acknowledged that cost constraints remain a hurdle in their POC segment expansion strategies in 2025.
Limited reimbursement policies: Uncertain or partial insurance coverage restricts broader adoption, especially in smaller clinics and homecare. Trinity Biotech continues to advocate for more inclusive reimbursement policies to boost adoption rates.

In 2025, glucose monitoring leads the North America ASEAN Point of Care Diagnostics Market, comprising the largest share owing to rising diabetes prevalence and increased consumer awareness for regular monitoring. Infectious disease testing forms the second-largest segment, propelled by ongoing public health vigilance and readiness in response to epidemics. Cardiometabolic monitoring is also gaining momentum, supported by a surge in cardiovascular and metabolic health issues. This diverse segmentation illustrates the market’s responsiveness to both lifestyle-related and acute infectious medical needs.

Hospitals remain the predominant application segment in the North America ASEAN Point of Care Diagnostics Market with the highest share, reflecting their reliance on rapid diagnostics for critical patient management. Homecare has emerged as a significant segment due to the growing trend of self-monitoring and decentralized healthcare models. Clinics follow closely, capitalizing on the need for fast and on-site results to expedite treatment plans. These application trends highlight a shift towards accessible, patient-centric diagnostic solutions tailored to diverse healthcare environments.

The North America ASEAN Point of Care Diagnostics Market is projected to witness significant revenue growth from 2020 through 2035. Revenue is expected to accelerate as demand for rapid, accurate point-of-care solutions rises across regions. The transition from 2020 to 2025 marks the most robust period of growth, fueled by pandemic response measures and advancements in digital connectivity. By 2035, ongoing innovation and broad-based adoption are forecast to maintain steady revenue expansion, cementing the region’s position as a key contributor to global point-of-care diagnostics innovation.

Year-over-year (YOY) growth in the market is marked by initial spikes around 2025, corresponding to increased healthcare expenditure, emergence of new infectious threats, and fast-paced innovation in diagnostic technologies. Although the growth rate stabilizes in the later years (2030-2035), it remains positive as point-of-care diagnostics become integral to mainstream healthcare workflows. This sustainable escalation underlines the transition toward a more preventative, decentralized approach to healthcare delivery across North America.

In 2025, the United States dominates the North America ASEAN Point of Care Diagnostics Market, accounting for more than half of the total market share. Canada commands the next largest proportion, driven by public health investments and innovation-friendly regulations. Mexico also continues to strengthen its market presence, aided by growing demand for accessible, rapid testing solutions. The regional landscape underscores the outsized influence of advanced healthcare systems and robust regulatory support in determining market distribution.

Abbott Laboratories emerges as the market leader in 2025, credited to its wide portfolio and innovation in glucose monitoring. Roche and Siemens Healthineers retain significant shares, benefiting from established brands and diverse product offerings. The competitive landscape is defined by a mix of global giants and niche innovators, each contributing to the market’s dynamic growth through technological advancements, strategic partnerships, and continuous product development.

Hospital systems represent the largest share of buyers in 2025, underscoring their pivotal role as end-users of point of care diagnostic solutions. Ambulatory care and diagnostic centers follow, reflecting the increasing decentralization of healthcare delivery. The buyer mix demonstrates the widespread applicability of POC diagnostics across various healthcare settings, supporting early detection, efficient care, and improved patient outcomes.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	2410
Regions	US, Canada, Mexico
Segments	By Type, By Application, By Distribution Channels, By Technology, By Organization Size
Players	Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, bioMérieux SA, QuidelOrtho Corporation, BD (Becton, Dickinson and Company), Chembio Diagnostics, Inc., Werfen, Nova Biomedical, Trinity Biotech, EKF Diagnostics, Sysmex Corporation, Sekisui Diagnostics, OraSure Technologies

July 2024: Abbott Laboratories launched a next-gen continuous glucose monitoring system with enhanced Bluetooth and AI capabilities.
June 2024: Roche introduced a fully connected POC molecular diagnostics platform, improving infectious disease detection speed.
July 2024: BD expanded access of POC testing equipment to rural clinics through new distribution agreements across North America.
August 2024: Siemens Healthineers received FDA clearance for its advanced portable immunoassay analyzer for emergency departments.
August 2024: bioMérieux announced investment in AI-powered molecular platforms for rapid pathogen identification in primary care.

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

North America ASEAN Point of Care Diagnostics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America ASEAN Point of Care Diagnostics Market Outlook 2025-2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

Market Share by Type, 2025

Market Share by Applications, 2025

Market Revenue (USD Million), 2020-2035

YOY Growth (%), 2020-2035

Market Share by Region, 2025

Market Share by Players, 2025

Market Share by Buyers, 2025

Study Coverage

Key Recent Developments

Frequently asked questions